Results 131 to 140 of about 840,919 (175)

High-resolution genomic and molecular characterization of vancomycin-resistant enterococci from hospitalized patients in a tertiary care center in Riyadh, Saudi Arabia. [PDF]

Sci Rep
Almasaud LD, Alkhulaifi MM, Ghazawi A, Strepis N, Manzoor A, Senok A, Alajlan HH, Almogbel MS, Moradigaravand D, Khan M.   +9 more
europepmc   +1 more source

Genomic sequencing surveillance of patients colonized with vancomycin-resistant enterococci improves detection of healthcare-associated transmission. [PDF]

BMC Glob Public Health
Sundermann AJ, Rangachar Srinivasa V, Mills EG, Griffith MP, Evans E, Chen J, Waggle KD, Snyder GM, Pless LL, Harrison LH, Van Tyne D.   +10 more
europepmc   +1 more source

Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococci. [PDF]

Eur J Med Chem
Ammara A, Giovannuzzi S, Bonardi A, Abutaleb NS, Abouelkhair AA, Flaherty DP, Seleem MN, Capasso C, Gratteri P, Nocentini A, Supuran CT.   +10 more
europepmc   +1 more source

Correction: Peptine et al. Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Resistant Enterococci (VRE) in Nosocomial Infections: A Systematic Review of Resistance, Pathogenesis, and Clinical Management. <i>Microorganisms</i> 2026, <i>14</i>, 428. [PDF]

Microorganisms
Peptine LD, Zaharia AE, Maftei NM, Răileanu CR, Matache Vasilache ER, Conea AC, Chesaru BI, Tutunaru D, Dragostin OM, Mititelu-Tarţău L, Gurău G.   +10 more
europepmc   +1 more source

Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting. [PDF]

Antibiotics (Basel)
Navarra A, Cicalini S, D'Arezzo S, Pica F, Selleri M, Nisii C, Venditti C, Cannas A, Mazzarelli A, Vulcano A, Carrara S, Vincenti D, Bartolini B, Giacomini P, Bocci MG, Fontana C.   +15 more
europepmc   +1 more source

The VanS sensor histidine kinase from type-B vancomycin-resistant enterococci recognizes vancomycin directly. [PDF]

J Biol Chem
Maciunas LJ, Rotsides P, D'Lauro EJ, Brady S, Beld J, Loll PJ.   +5 more
europepmc   +1 more source

Hit-to-Lead Optimization of Acetazolamide-Based Bacterial Carbonic Anhydrase Inhibitors with Efficacy In Vivo for Treatment of Vancomycin-Resistant Enterococci Septicemia. [PDF]

J Med Chem
Holly KJ, Tharra PR, Abutaleb NS, Nocentini A, Abouelkhair AA, Youse MS, Marapaka AK, S Abdelsattar A, An W, Drummond FL, Snell OC, Supuran CT, Seleem MN, Flaherty DP.   +13 more
europepmc   +1 more source

Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis. [PDF]

Antimicrob Resist Infect Control
Bae S, Cho K, Park I, Kim J, Han H, Jung J, Kim SH, Lee SO.   +7 more
europepmc   +1 more source

Vancomycin-Resistant Enterococci: Current Understandings of Resistance in Relation to Transmission and Preventive Strategies. [PDF]

Pathogens
Mareković I, Markanović M, Lešin J, Ćorić M.   +3 more
europepmc   +1 more source

A consortium of seven commensal bacteria promotes gut microbiota recovery and strengthens ecological barrier against vancomycin-resistant enterococci. [PDF]

Microbiome
Jan A, Bayle P, Mohellibi N, Lemoine C, Pepke F, Béguet-Crespel F, Jouanin I, Tremblay-Franco M, Laroche B, Serror P, Rigottier-Gois L.   +10 more
europepmc   +1 more source